It is demonstrated that CXCL1 expressed on tumor cells and its binding to the CXCR2 receptor could promote the activation of the NF-κB/AKT pathway, thereby causing metastasis, angiogenesis, growth, and progression of BC. The gene discussed is CXCL1; the disease is breast cancer.